Breast & Ovarian Cancer
Breast Cancer: Genomics in Prediction and Stratified Screening - April 23, 2014
CDC Info
- CDC blog post:Using genomics in precision prevention of breast cancer
- CDC Medscape Expert Commentary:Genetics and BRCA in Primary Care
- Does breast or ovarian cancer run in your family?
- Public health genomics implementation tool kit for health departments - check out BRCA section
- How can we use genetic testing for stratified screening for common diseases such as breast cancer?
- CDC Know:BRCA Tool
- Knowing BRCA changed my life
New CDC blog post:Using genomics in precision prevention of breast cancer
Hereditary breast and ovarian cancers: moving toward more precise prevention,
NIH Director Blog Post, Apr 14
Prediction of breast cancer risk based on profiling with common genetic variants.![External Web Site Icon External Web Site Icon](https://lh3.googleusercontent.com/blogger_img_proxy/AEn0k_vOkHr9hY24SDMzkVM2iUOXfIhqzUiqUlvYrAtOFFk0w5uVVJbXYGfx7VBrBflBpn92jbUG7WOCJSMPV2leo-6k7u6JZ0omR8iphwnji-lXPZwAaFf8SAAS=s0-d)
Mavaddat N et al. J. Natl. Cancer Inst. 2015 May (5)
Mavaddat N et al. J. Natl. Cancer Inst. 2015 May (5)
Twenty-five years of breast cancer risk models and their applications.![External Web Site Icon External Web Site Icon](https://lh3.googleusercontent.com/blogger_img_proxy/AEn0k_vOkHr9hY24SDMzkVM2iUOXfIhqzUiqUlvYrAtOFFk0w5uVVJbXYGfx7VBrBflBpn92jbUG7WOCJSMPV2leo-6k7u6JZ0omR8iphwnji-lXPZwAaFf8SAAS=s0-d)
Gail MH et al. J. Natl. Cancer Inst. 2015 May (5)
Gail MH et al. J. Natl. Cancer Inst. 2015 May (5)
Breast cancer prevention in the era of precision medicine.![External Web Site Icon External Web Site Icon](https://lh3.googleusercontent.com/blogger_img_proxy/AEn0k_vOkHr9hY24SDMzkVM2iUOXfIhqzUiqUlvYrAtOFFk0w5uVVJbXYGfx7VBrBflBpn92jbUG7WOCJSMPV2leo-6k7u6JZ0omR8iphwnji-lXPZwAaFf8SAAS=s0-d)
Narod SA et al. J. Natl. Cancer Inst. 2015 May (5)
Narod SA et al. J. Natl. Cancer Inst. 2015 May (5)
The contributions of breast density and common genetic variation to breast cancer risk.![External Web Site Icon External Web Site Icon](https://lh3.googleusercontent.com/blogger_img_proxy/AEn0k_vOkHr9hY24SDMzkVM2iUOXfIhqzUiqUlvYrAtOFFk0w5uVVJbXYGfx7VBrBflBpn92jbUG7WOCJSMPV2leo-6k7u6JZ0omR8iphwnji-lXPZwAaFf8SAAS=s0-d)
Vachon CM et al. J. Natl. Cancer Inst. 2015 May (5)
Vachon CM et al. J. Natl. Cancer Inst. 2015 May (5)
Update on breast cancer risk prediction and prevention.![External Web Site Icon External Web Site Icon](https://lh3.googleusercontent.com/blogger_img_proxy/AEn0k_vOkHr9hY24SDMzkVM2iUOXfIhqzUiqUlvYrAtOFFk0w5uVVJbXYGfx7VBrBflBpn92jbUG7WOCJSMPV2leo-6k7u6JZ0omR8iphwnji-lXPZwAaFf8SAAS=s0-d)
Sestak I et al. Curr. Opin. Obstet. Gynecol. 2015 Feb (1) 92-7
Sestak I et al. Curr. Opin. Obstet. Gynecol. 2015 Feb (1) 92-7
The role of genome sequencing in personalized breast cancer prevention.![External Web Site Icon External Web Site Icon](https://lh3.googleusercontent.com/blogger_img_proxy/AEn0k_vOkHr9hY24SDMzkVM2iUOXfIhqzUiqUlvYrAtOFFk0w5uVVJbXYGfx7VBrBflBpn92jbUG7WOCJSMPV2leo-6k7u6JZ0omR8iphwnji-lXPZwAaFf8SAAS=s0-d)
Weiva Sieh, et al. Cancer Epidemiology Biomarkers and Prevention, October 23, 2014
Weiva Sieh, et al. Cancer Epidemiology Biomarkers and Prevention, October 23, 2014
Cancer genomics: Using big data to advance breast cancer risk prediction,
by Srivani Ravoori, AACR blog post, Oct 23
Breast cancer in young women: Share your story - April 20, 2015
CDC information: Share your story. Empower and educate young women
About 11% of new breast cancer cases in the United States affect women under the age of 45, but many young women may not realize they are at risk for this disease.
About 11% of new breast cancer cases in the United States affect women under the age of 45, but many young women may not realize they are at risk for this disease.
CDC Know:BRCA Tool
Some women carry certain genetic changes in their BRCA genes that increase their risks for getting breast, ovarian, and other kinds of cancers at a young age
Some women carry certain genetic changes in their BRCA genes that increase their risks for getting breast, ovarian, and other kinds of cancers at a young age
Knowing BRCA changed my life, by Debbie Wasserman Schultz, CDC Blog Post 2014
CDC information: Does breast or ovarian cancer run in your family?
Webinar: Hereditary breast and ovarian cancer in public health,
Genetic Alliance, 2014
CDC Tier 1 Genomic Applications Implementation Toolkit for Public Health Departments
Detailed Information on Hereditary Breast and Ovarian Cancer (HBOC)
Detailed Information on Hereditary Breast and Ovarian Cancer (HBOC)
CDC Podcast: Genetics and BRCA in primary care,
Medscape, 2014
Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer.![External Web Site Icon External Web Site Icon](https://lh3.googleusercontent.com/blogger_img_proxy/AEn0k_vOkHr9hY24SDMzkVM2iUOXfIhqzUiqUlvYrAtOFFk0w5uVVJbXYGfx7VBrBflBpn92jbUG7WOCJSMPV2leo-6k7u6JZ0omR8iphwnji-lXPZwAaFf8SAAS=s0-d)
Rebbeck TR et al. JAMA 2015 Apr 7. (13) 1347-61
Rebbeck TR et al. JAMA 2015 Apr 7. (13) 1347-61
Effect of oophorectomy on survival after breast cancer in BRCA1 and BRCA2 mutation carriers![External Web Site Icon External Web Site Icon](https://lh3.googleusercontent.com/blogger_img_proxy/AEn0k_vOkHr9hY24SDMzkVM2iUOXfIhqzUiqUlvYrAtOFFk0w5uVVJbXYGfx7VBrBflBpn92jbUG7WOCJSMPV2leo-6k7u6JZ0omR8iphwnji-lXPZwAaFf8SAAS=s0-d)
Metcalfe K et al. JAMA Oncology, April 23, 2015
Metcalfe K et al. JAMA Oncology, April 23, 2015
Breast Cancer Gene Expression Profiling in Practice - April 13, 2015
Cost-effectiveness of the 21-gene breast cancer assay in Mexico.![External Web Site Icon External Web Site Icon](https://lh3.googleusercontent.com/blogger_img_proxy/AEn0k_vOkHr9hY24SDMzkVM2iUOXfIhqzUiqUlvYrAtOFFk0w5uVVJbXYGfx7VBrBflBpn92jbUG7WOCJSMPV2leo-6k7u6JZ0omR8iphwnji-lXPZwAaFf8SAAS=s0-d)
Bargalló-Rocha JE et al. Adv Ther 2015 Mar 5.
Bargalló-Rocha JE et al. Adv Ther 2015 Mar 5.
Initial trends in the use of the 21-gene recurrence score assay for patients with breast cancer in the Medicare population, 2005-2009![External Web Site Icon External Web Site Icon](https://lh3.googleusercontent.com/blogger_img_proxy/AEn0k_vOkHr9hY24SDMzkVM2iUOXfIhqzUiqUlvYrAtOFFk0w5uVVJbXYGfx7VBrBflBpn92jbUG7WOCJSMPV2leo-6k7u6JZ0omR8iphwnji-lXPZwAaFf8SAAS=s0-d)
Dinan MA, et al. JAMA Oncology, March 2015
Dinan MA, et al. JAMA Oncology, March 2015
The value of personalizing medicine: Medical oncologists? Views on gene expression profiling in breast cancer treatment![External Web Site Icon External Web Site Icon](https://lh3.googleusercontent.com/blogger_img_proxy/AEn0k_vOkHr9hY24SDMzkVM2iUOXfIhqzUiqUlvYrAtOFFk0w5uVVJbXYGfx7VBrBflBpn92jbUG7WOCJSMPV2leo-6k7u6JZ0omR8iphwnji-lXPZwAaFf8SAAS=s0-d)
Bombard Y, et al. The Oncologist, March 2015
Bombard Y, et al. The Oncologist, March 2015
The 21-gene recurrence score complements IBTR! Estimates in early-stage, hormone receptor-positive, HER2-normal, lymph node-negative breast cancer.![External Web Site Icon External Web Site Icon](https://lh3.googleusercontent.com/blogger_img_proxy/AEn0k_vOkHr9hY24SDMzkVM2iUOXfIhqzUiqUlvYrAtOFFk0w5uVVJbXYGfx7VBrBflBpn92jbUG7WOCJSMPV2leo-6k7u6JZ0omR8iphwnji-lXPZwAaFf8SAAS=s0-d)
Thaker NG, et al. Springerplus 2015 36
Thaker NG, et al. Springerplus 2015 36
Oncotype DX in women and men with ER-positive, HER2-negative early stage breast cancer who are lymph node negative: A review of clinical effectiveness and guidelines![External Web Site Icon External Web Site Icon](https://lh3.googleusercontent.com/blogger_img_proxy/AEn0k_vOkHr9hY24SDMzkVM2iUOXfIhqzUiqUlvYrAtOFFk0w5uVVJbXYGfx7VBrBflBpn92jbUG7WOCJSMPV2leo-6k7u6JZ0omR8iphwnji-lXPZwAaFf8SAAS=s0-d)
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health 2014 Feb 20.
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health 2014 Feb 20.
Clinical utility of gene-expression profiling in women with early breast cancer: an overview of systematic reviews.![External Web Site Icon External Web Site Icon](https://lh3.googleusercontent.com/blogger_img_proxy/AEn0k_vOkHr9hY24SDMzkVM2iUOXfIhqzUiqUlvYrAtOFFk0w5uVVJbXYGfx7VBrBflBpn92jbUG7WOCJSMPV2leo-6k7u6JZ0omR8iphwnji-lXPZwAaFf8SAAS=s0-d)
Marrone M, et al. Genet. Med. 2014 Dec 4.
Marrone M, et al. Genet. Med. 2014 Dec 4.
[uPA/PAI-1, Oncotype DX, MammaPrint(®). Prognosis and predictive values for clinical utility in breast cancer management].![External Web Site Icon External Web Site Icon](https://lh3.googleusercontent.com/blogger_img_proxy/AEn0k_vOkHr9hY24SDMzkVM2iUOXfIhqzUiqUlvYrAtOFFk0w5uVVJbXYGfx7VBrBflBpn92jbUG7WOCJSMPV2leo-6k7u6JZ0omR8iphwnji-lXPZwAaFf8SAAS=s0-d)
Bellocq JP, et al. Ann Pathol 2014 Oct (5) 349-51
Bellocq JP, et al. Ann Pathol 2014 Oct (5) 349-51
A study of the impact of the 21-gene breast cancer assay on the use of adjuvant chemotherapy in women with breast cancer in a Mexican public hospital.![External Web Site Icon External Web Site Icon](https://lh3.googleusercontent.com/blogger_img_proxy/AEn0k_vOkHr9hY24SDMzkVM2iUOXfIhqzUiqUlvYrAtOFFk0w5uVVJbXYGfx7VBrBflBpn92jbUG7WOCJSMPV2leo-6k7u6JZ0omR8iphwnji-lXPZwAaFf8SAAS=s0-d)
Bargallo JE, et al. J Surg Oncol 2015 Feb (2) 203-7
Bargallo JE, et al. J Surg Oncol 2015 Feb (2) 203-7
Can mammographic and sonographic imaging features predict the Oncotype DX? recurrence score in T1 and T2, hormone receptor positive, HER2 negative and axillary lymph node negative breast cancers?![External Web Site Icon External Web Site Icon](https://lh3.googleusercontent.com/blogger_img_proxy/AEn0k_vOkHr9hY24SDMzkVM2iUOXfIhqzUiqUlvYrAtOFFk0w5uVVJbXYGfx7VBrBflBpn92jbUG7WOCJSMPV2leo-6k7u6JZ0omR8iphwnji-lXPZwAaFf8SAAS=s0-d)
Yepes MM, et al. Breast Cancer Res. Treat. 2014 Nov (1) 117-23
Yepes MM, et al. Breast Cancer Res. Treat. 2014 Nov (1) 117-23
The impact of Oncotype DX testing on breast cancer management and chemotherapy prescribing patterns in a tertiary referral centre.![External Web Site Icon External Web Site Icon](https://lh3.googleusercontent.com/blogger_img_proxy/AEn0k_vOkHr9hY24SDMzkVM2iUOXfIhqzUiqUlvYrAtOFFk0w5uVVJbXYGfx7VBrBflBpn92jbUG7WOCJSMPV2leo-6k7u6JZ0omR8iphwnji-lXPZwAaFf8SAAS=s0-d)
McVeigh TP, et al. Eur. J. Cancer 2014 Nov (16) 2763-70
McVeigh TP, et al. Eur. J. Cancer 2014 Nov (16) 2763-70
Genomic profile of breast cancer: cost-effectiveness analysis from the Spanish National Healthcare System perspective.![External Web Site Icon External Web Site Icon](https://lh3.googleusercontent.com/blogger_img_proxy/AEn0k_vOkHr9hY24SDMzkVM2iUOXfIhqzUiqUlvYrAtOFFk0w5uVVJbXYGfx7VBrBflBpn92jbUG7WOCJSMPV2leo-6k7u6JZ0omR8iphwnji-lXPZwAaFf8SAAS=s0-d)
Seguí MÁ et al. Expert Rev Pharmacoecon Outcomes Res 2014 Dec (6) 889-99
Seguí MÁ et al. Expert Rev Pharmacoecon Outcomes Res 2014 Dec (6) 889-99
Societal cost-effectiveness analysis of the 21-gene assay in estrogen-receptor-positive, lymph-node-negative early-stage breast cancer in Japan.![External Web Site Icon External Web Site Icon](https://lh3.googleusercontent.com/blogger_img_proxy/AEn0k_vOkHr9hY24SDMzkVM2iUOXfIhqzUiqUlvYrAtOFFk0w5uVVJbXYGfx7VBrBflBpn92jbUG7WOCJSMPV2leo-6k7u6JZ0omR8iphwnji-lXPZwAaFf8SAAS=s0-d)
Yamauchi H, et al. BMC Health Serv Res 2014 372
Yamauchi H, et al. BMC Health Serv Res 2014 372
Factors influencing Oncotype DX use in the management of early breast cancer: a single centre experience.![External Web Site Icon External Web Site Icon](https://lh3.googleusercontent.com/blogger_img_proxy/AEn0k_vOkHr9hY24SDMzkVM2iUOXfIhqzUiqUlvYrAtOFFk0w5uVVJbXYGfx7VBrBflBpn92jbUG7WOCJSMPV2leo-6k7u6JZ0omR8iphwnji-lXPZwAaFf8SAAS=s0-d)
Zhu X, et al. Eur. J. Cancer 2014 Oct (15) 2544-9
Zhu X, et al. Eur. J. Cancer 2014 Oct (15) 2544-9
Diagnostic tests based on gene expression profile in breast cancer: from background to clinical use.![External Web Site Icon External Web Site Icon](https://lh3.googleusercontent.com/blogger_img_proxy/AEn0k_vOkHr9hY24SDMzkVM2iUOXfIhqzUiqUlvYrAtOFFk0w5uVVJbXYGfx7VBrBflBpn92jbUG7WOCJSMPV2leo-6k7u6JZ0omR8iphwnji-lXPZwAaFf8SAAS=s0-d)
Zanotti L, et al. Tumour Biol. 2014 Sep (9) 8461-70
Zanotti L, et al. Tumour Biol. 2014 Sep (9) 8461-70
Breast Cancer Genomics: Where Are We Going? March 31, 2015
CDC information: New analysis of breast cancer subtypes could lead to better risk stratification
Annual report to the Nation shows that mortality and incidence for most cancers continue to decline
Annual report to the Nation shows that mortality and incidence for most cancers continue to decline
Annual report to the Nation on the status of cancer, 1975-2011, featuring incidence of breast cancer subtypes by race/ethnicity, poverty, and state ![External Web Site Icon External Web Site Icon](https://lh3.googleusercontent.com/blogger_img_proxy/AEn0k_vOkHr9hY24SDMzkVM2iUOXfIhqzUiqUlvYrAtOFFk0w5uVVJbXYGfx7VBrBflBpn92jbUG7WOCJSMPV2leo-6k7u6JZ0omR8iphwnji-lXPZwAaFf8SAAS=s0-d)
Kohler B et al. JNCI, March 30, 2015
Kohler B et al. JNCI, March 30, 2015
Breast cancer genomics from microarrays to massively parallel sequencing: paradigms and new insights.![External Web Site Icon External Web Site Icon](https://lh3.googleusercontent.com/blogger_img_proxy/AEn0k_vOkHr9hY24SDMzkVM2iUOXfIhqzUiqUlvYrAtOFFk0w5uVVJbXYGfx7VBrBflBpn92jbUG7WOCJSMPV2leo-6k7u6JZ0omR8iphwnji-lXPZwAaFf8SAAS=s0-d)
Ng CK et al. J. Natl. Cancer Inst. 2015 (5)
Ng CK et al. J. Natl. Cancer Inst. 2015 (5)
Genomic profiling of breast cancers.![External Web Site Icon External Web Site Icon](https://lh3.googleusercontent.com/blogger_img_proxy/AEn0k_vOkHr9hY24SDMzkVM2iUOXfIhqzUiqUlvYrAtOFFk0w5uVVJbXYGfx7VBrBflBpn92jbUG7WOCJSMPV2leo-6k7u6JZ0omR8iphwnji-lXPZwAaFf8SAAS=s0-d)
Curtis C et al. Curr. Opin. Obstet. Gynecol. 2015 Feb (1) 34-9
Curtis C et al. Curr. Opin. Obstet. Gynecol. 2015 Feb (1) 34-9
Intrinsic cancer subtypes-next steps into personalized medicine.![External Web Site Icon External Web Site Icon](https://lh3.googleusercontent.com/blogger_img_proxy/AEn0k_vOkHr9hY24SDMzkVM2iUOXfIhqzUiqUlvYrAtOFFk0w5uVVJbXYGfx7VBrBflBpn92jbUG7WOCJSMPV2leo-6k7u6JZ0omR8iphwnji-lXPZwAaFf8SAAS=s0-d)
Santos C et al. Cell Oncol (Dordr) 2015 Jan 14.
Santos C et al. Cell Oncol (Dordr) 2015 Jan 14.
New concepts in breast cancer genomics and genetics.![External Web Site Icon External Web Site Icon](https://lh3.googleusercontent.com/blogger_img_proxy/AEn0k_vOkHr9hY24SDMzkVM2iUOXfIhqzUiqUlvYrAtOFFk0w5uVVJbXYGfx7VBrBflBpn92jbUG7WOCJSMPV2leo-6k7u6JZ0omR8iphwnji-lXPZwAaFf8SAAS=s0-d)
Goncalves R et al. Breast Cancer Res. 2014 (5) 460
Goncalves R et al. Breast Cancer Res. 2014 (5) 460
Application of metabolomics in drug resistant breast cancer research.![External Web Site Icon External Web Site Icon](https://lh3.googleusercontent.com/blogger_img_proxy/AEn0k_vOkHr9hY24SDMzkVM2iUOXfIhqzUiqUlvYrAtOFFk0w5uVVJbXYGfx7VBrBflBpn92jbUG7WOCJSMPV2leo-6k7u6JZ0omR8iphwnji-lXPZwAaFf8SAAS=s0-d)
Shajahan-Haq AN et al. Metabolites 2015 (1) 100-18
Shajahan-Haq AN et al. Metabolites 2015 (1) 100-18
Research progress in applying proteomics technology to explore early diagnosis biomarkers of breast cancer, lung cancer and ovarian cancer.![External Web Site Icon External Web Site Icon](https://lh3.googleusercontent.com/blogger_img_proxy/AEn0k_vOkHr9hY24SDMzkVM2iUOXfIhqzUiqUlvYrAtOFFk0w5uVVJbXYGfx7VBrBflBpn92jbUG7WOCJSMPV2leo-6k7u6JZ0omR8iphwnji-lXPZwAaFf8SAAS=s0-d)
Luo L et al. Asian Pac. J. Cancer Prev. 2014 (20) 8529-38
Luo L et al. Asian Pac. J. Cancer Prev. 2014 (20) 8529-38
How many etiological subtypes of breast cancer: two, three, four, or more?![External Web Site Icon External Web Site Icon](https://lh3.googleusercontent.com/blogger_img_proxy/AEn0k_vOkHr9hY24SDMzkVM2iUOXfIhqzUiqUlvYrAtOFFk0w5uVVJbXYGfx7VBrBflBpn92jbUG7WOCJSMPV2leo-6k7u6JZ0omR8iphwnji-lXPZwAaFf8SAAS=s0-d)
Anderson WF et al. J. Natl. Cancer Inst. 2014 Aug (8)
Anderson WF et al. J. Natl. Cancer Inst. 2014 Aug (8)
Computational prognostic indicators for breast cancer.![External Web Site Icon External Web Site Icon](https://lh3.googleusercontent.com/blogger_img_proxy/AEn0k_vOkHr9hY24SDMzkVM2iUOXfIhqzUiqUlvYrAtOFFk0w5uVVJbXYGfx7VBrBflBpn92jbUG7WOCJSMPV2leo-6k7u6JZ0omR8iphwnji-lXPZwAaFf8SAAS=s0-d)
Yang X et al. Cancer Manag Res 2014 301-12
Yang X et al. Cancer Manag Res 2014 301-12
Genomic analysis of breast cancer heralds a changing treatment paradigm.![External Web Site Icon External Web Site Icon](https://lh3.googleusercontent.com/blogger_img_proxy/AEn0k_vOkHr9hY24SDMzkVM2iUOXfIhqzUiqUlvYrAtOFFk0w5uVVJbXYGfx7VBrBflBpn92jbUG7WOCJSMPV2leo-6k7u6JZ0omR8iphwnji-lXPZwAaFf8SAAS=s0-d)
Ellis M et al. J Natl Compr Canc Netw 2014 May (5 Suppl) 750-2
Ellis M et al. J Natl Compr Canc Netw 2014 May (5 Suppl) 750-2
Triple-negative breast cancer: bridging the gap from cancer genomics to predictive biomarkers.![External Web Site Icon External Web Site Icon](https://lh3.googleusercontent.com/blogger_img_proxy/AEn0k_vOkHr9hY24SDMzkVM2iUOXfIhqzUiqUlvYrAtOFFk0w5uVVJbXYGfx7VBrBflBpn92jbUG7WOCJSMPV2leo-6k7u6JZ0omR8iphwnji-lXPZwAaFf8SAAS=s0-d)
Davis SL et al. Ther Adv Med Oncol 2014 May (3) 88-100
Davis SL et al. Ther Adv Med Oncol 2014 May (3) 88-100
Principles and methods of integrative genomic analyses in cancer.![External Web Site Icon External Web Site Icon](https://lh3.googleusercontent.com/blogger_img_proxy/AEn0k_vOkHr9hY24SDMzkVM2iUOXfIhqzUiqUlvYrAtOFFk0w5uVVJbXYGfx7VBrBflBpn92jbUG7WOCJSMPV2leo-6k7u6JZ0omR8iphwnji-lXPZwAaFf8SAAS=s0-d)
Kristensen VN et al. Nat. Rev. Cancer 2014 May (5) 299-313
Kristensen VN et al. Nat. Rev. Cancer 2014 May (5) 299-313
Implications of functional proteomics in breast cancer.![External Web Site Icon External Web Site Icon](https://lh3.googleusercontent.com/blogger_img_proxy/AEn0k_vOkHr9hY24SDMzkVM2iUOXfIhqzUiqUlvYrAtOFFk0w5uVVJbXYGfx7VBrBflBpn92jbUG7WOCJSMPV2leo-6k7u6JZ0omR8iphwnji-lXPZwAaFf8SAAS=s0-d)
Chae YK et al. Oncologist 2014 Apr (4) 328-35
Chae YK et al. Oncologist 2014 Apr (4) 328-35
Genetic and epigenetic aspects of breast cancer progression and therapy.![External Web Site Icon External Web Site Icon](https://lh3.googleusercontent.com/blogger_img_proxy/AEn0k_vOkHr9hY24SDMzkVM2iUOXfIhqzUiqUlvYrAtOFFk0w5uVVJbXYGfx7VBrBflBpn92jbUG7WOCJSMPV2leo-6k7u6JZ0omR8iphwnji-lXPZwAaFf8SAAS=s0-d)
Byler S et al. Anticancer Res. 2014 Mar (3) 1071-7
Byler S et al. Anticancer Res. 2014 Mar (3) 1071-7
The omics of triple-negative breast cancers.![External Web Site Icon External Web Site Icon](https://lh3.googleusercontent.com/blogger_img_proxy/AEn0k_vOkHr9hY24SDMzkVM2iUOXfIhqzUiqUlvYrAtOFFk0w5uVVJbXYGfx7VBrBflBpn92jbUG7WOCJSMPV2leo-6k7u6JZ0omR8iphwnji-lXPZwAaFf8SAAS=s0-d)
Xu H et al. Clin. Chem. 2014 Jan (1) 122-33
Xu H et al. Clin. Chem. 2014 Jan (1) 122-33
Methylome sequencing in triple-negative breast cancer reveals distinct methylation clusters with prognostic value.![External Web Site Icon External Web Site Icon](https://lh3.googleusercontent.com/blogger_img_proxy/AEn0k_vOkHr9hY24SDMzkVM2iUOXfIhqzUiqUlvYrAtOFFk0w5uVVJbXYGfx7VBrBflBpn92jbUG7WOCJSMPV2leo-6k7u6JZ0omR8iphwnji-lXPZwAaFf8SAAS=s0-d)
Stirzaker C et al. Nat Commun 2015 5899
Stirzaker C et al. Nat Commun 2015 5899
Breast cancer genomics in the deep sequencing era.![External Web Site Icon External Web Site Icon](https://lh3.googleusercontent.com/blogger_img_proxy/AEn0k_vOkHr9hY24SDMzkVM2iUOXfIhqzUiqUlvYrAtOFFk0w5uVVJbXYGfx7VBrBflBpn92jbUG7WOCJSMPV2leo-6k7u6JZ0omR8iphwnji-lXPZwAaFf8SAAS=s0-d)
Pillar N et al. Isr. Med. Assoc. J. 2014 Dec (12) 783-4
Pillar N et al. Isr. Med. Assoc. J. 2014 Dec (12) 783-4
Celebrities: Genetics and Breast Cancer - March 30, 2015
Genetic counselors expect resurgence of 'Jolie effect'![External Web Site Icon External Web Site Icon](https://lh3.googleusercontent.com/blogger_img_proxy/AEn0k_vOkHr9hY24SDMzkVM2iUOXfIhqzUiqUlvYrAtOFFk0w5uVVJbXYGfx7VBrBflBpn92jbUG7WOCJSMPV2leo-6k7u6JZ0omR8iphwnji-lXPZwAaFf8SAAS=s0-d)
But misinterpreted results of tests for cancer risk can result in unnecessary surgery. Erika Check Hayden, Nature News, March 30, 2015
But misinterpreted results of tests for cancer risk can result in unnecessary surgery. Erika Check Hayden, Nature News, March 30, 2015
Learning from Angelina Jolie's genetic testing for our own health,
by Elizabeth Cohen, CNN, Mar 25
Diary of a surgery,
by Angelina Jolie Pitt, New York Times, Mar 24
'Jolie effect': Could her candor help save lives?
By Maria Puente, USA Today, Mar 24
'Angelina Jolie effect': BRCA testing doubles,
by Zosia Chustecka, Medscape, Sept 3
Cancer information seeking in the digital age: Effects of Angelina Jolie's prophylactic mastectomy announcement![External Web Site Icon External Web Site Icon](https://lh3.googleusercontent.com/blogger_img_proxy/AEn0k_vOkHr9hY24SDMzkVM2iUOXfIhqzUiqUlvYrAtOFFk0w5uVVJbXYGfx7VBrBflBpn92jbUG7WOCJSMPV2leo-6k7u6JZ0omR8iphwnji-lXPZwAaFf8SAAS=s0-d)
Noar SM, et al. Med Decis Making 2014 Oct
Noar SM, et al. Med Decis Making 2014 Oct
Celebrity disclosures and information seeking: the case of Angelina Jolie![External Web Site Icon External Web Site Icon](https://lh3.googleusercontent.com/blogger_img_proxy/AEn0k_vOkHr9hY24SDMzkVM2iUOXfIhqzUiqUlvYrAtOFFk0w5uVVJbXYGfx7VBrBflBpn92jbUG7WOCJSMPV2leo-6k7u6JZ0omR8iphwnji-lXPZwAaFf8SAAS=s0-d)
Juthe RH, et al. Genet Med 2014 Oct
Juthe RH, et al. Genet Med 2014 Oct
The Angelina effect: immediate reach, grasp, and impact of going public.![External Web Site Icon External Web Site Icon](https://lh3.googleusercontent.com/blogger_img_proxy/AEn0k_vOkHr9hY24SDMzkVM2iUOXfIhqzUiqUlvYrAtOFFk0w5uVVJbXYGfx7VBrBflBpn92jbUG7WOCJSMPV2leo-6k7u6JZ0omR8iphwnji-lXPZwAaFf8SAAS=s0-d)
Borzekowski DL et al. Genet Med. 2014 Jul;16(7):516-21.
Borzekowski DL et al. Genet Med. 2014 Jul;16(7):516-21.
Angelina Jolie's faulty gene: newspaper coverage of a celebrity's preventive bilateral mastectomy in Canada, the United States, and the United Kingdom.![External Web Site Icon External Web Site Icon](https://lh3.googleusercontent.com/blogger_img_proxy/AEn0k_vOkHr9hY24SDMzkVM2iUOXfIhqzUiqUlvYrAtOFFk0w5uVVJbXYGfx7VBrBflBpn92jbUG7WOCJSMPV2leo-6k7u6JZ0omR8iphwnji-lXPZwAaFf8SAAS=s0-d)
Kamenova K et al. Genet Med. 2014 Jul;16(7):522-8.
Kamenova K et al. Genet Med. 2014 Jul;16(7):522-8.
Hereditary Breast and Ovarian Cancer: Is it time for Population Screening for BRCA Mutations? - February 17, 2015
A never-ending genetic quest. Mary-Claire King?s Pioneering gene work, from breast cancer to human rights
, New York Times, Feb 9
Precision medicine meets public health: population screening for BRCA1 and BRCA2.![External Web Site Icon External Web Site Icon](https://lh3.googleusercontent.com/blogger_img_proxy/AEn0k_vOkHr9hY24SDMzkVM2iUOXfIhqzUiqUlvYrAtOFFk0w5uVVJbXYGfx7VBrBflBpn92jbUG7WOCJSMPV2leo-6k7u6JZ0omR8iphwnji-lXPZwAaFf8SAAS=s0-d)
Levy-Lahad Ephrat et al. J. Natl. Cancer Inst. 2015 Jan (1) 420
Levy-Lahad Ephrat et al. J. Natl. Cancer Inst. 2015 Jan (1) 420
Population-based screening for breast and ovarian cancer risk due to BRCA1 and BRCA2.![External Web Site Icon External Web Site Icon](https://lh3.googleusercontent.com/blogger_img_proxy/AEn0k_vOkHr9hY24SDMzkVM2iUOXfIhqzUiqUlvYrAtOFFk0w5uVVJbXYGfx7VBrBflBpn92jbUG7WOCJSMPV2leo-6k7u6JZ0omR8iphwnji-lXPZwAaFf8SAAS=s0-d)
Gabai-Kapara Efrat et al. Proc. Natl. Acad. Sci. U.S.A. 2014 Sep 30. (39) 14205-10
Gabai-Kapara Efrat et al. Proc. Natl. Acad. Sci. U.S.A. 2014 Sep 30. (39) 14205-10
Lasker Award winner Mary-Claire King.![External Web Site Icon External Web Site Icon](https://lh3.googleusercontent.com/blogger_img_proxy/AEn0k_vOkHr9hY24SDMzkVM2iUOXfIhqzUiqUlvYrAtOFFk0w5uVVJbXYGfx7VBrBflBpn92jbUG7WOCJSMPV2leo-6k7u6JZ0omR8iphwnji-lXPZwAaFf8SAAS=s0-d)
King Mary-Claire et al. Nat. Med. 2014 Oct (10) 1124-5
King Mary-Claire et al. Nat. Med. 2014 Oct (10) 1124-5
Population-based screening for BRCA1 and BRCA2: 2014 Lasker Award.![External Web Site Icon External Web Site Icon](https://lh3.googleusercontent.com/blogger_img_proxy/AEn0k_vOkHr9hY24SDMzkVM2iUOXfIhqzUiqUlvYrAtOFFk0w5uVVJbXYGfx7VBrBflBpn92jbUG7WOCJSMPV2leo-6k7u6JZ0omR8iphwnji-lXPZwAaFf8SAAS=s0-d)
King Mary-Claire et al. JAMA 2014 Sep 17. (11) 1091-2
King Mary-Claire et al. JAMA 2014 Sep 17. (11) 1091-2
Cost-effectiveness of population screening for BRCA mutations in Ashkenazi Jewish women compared with family history-based testing.![External Web Site Icon External Web Site Icon](https://lh3.googleusercontent.com/blogger_img_proxy/AEn0k_vOkHr9hY24SDMzkVM2iUOXfIhqzUiqUlvYrAtOFFk0w5uVVJbXYGfx7VBrBflBpn92jbUG7WOCJSMPV2leo-6k7u6JZ0omR8iphwnji-lXPZwAaFf8SAAS=s0-d)
Manchanda Ranjit et al. J. Natl. Cancer Inst. 2015 Jan (1) 380
Manchanda Ranjit et al. J. Natl. Cancer Inst. 2015 Jan (1) 380
Population testing for cancer predisposing BRCA1/BRCA2 mutations in the Ashkenazi-Jewish community: a randomized controlled trial.![External Web Site Icon External Web Site Icon](https://lh3.googleusercontent.com/blogger_img_proxy/AEn0k_vOkHr9hY24SDMzkVM2iUOXfIhqzUiqUlvYrAtOFFk0w5uVVJbXYGfx7VBrBflBpn92jbUG7WOCJSMPV2leo-6k7u6JZ0omR8iphwnji-lXPZwAaFf8SAAS=s0-d)
Manchanda Ranjit et al. J. Natl. Cancer Inst. 2015 Jan (1) 379
Manchanda Ranjit et al. J. Natl. Cancer Inst. 2015 Jan (1) 379
Ovarian Cancer: Recent Genomic Insights - January 20, 2015
Identification of six new susceptibility loci for invasive epithelial ovarian cancer![External Web Site Icon External Web Site Icon](https://lh3.googleusercontent.com/blogger_img_proxy/AEn0k_vOkHr9hY24SDMzkVM2iUOXfIhqzUiqUlvYrAtOFFk0w5uVVJbXYGfx7VBrBflBpn92jbUG7WOCJSMPV2leo-6k7u6JZ0omR8iphwnji-lXPZwAaFf8SAAS=s0-d)
Karoline B Kuchenbaecker et al. Nature Genetics, January 12, 2015
Karoline B Kuchenbaecker et al. Nature Genetics, January 12, 2015
Germline mutation in BRCA1 or BRCA2 and ten-year survival for women diagnosed with epithelial ovarian cancer.![External Web Site Icon External Web Site Icon](https://lh3.googleusercontent.com/blogger_img_proxy/AEn0k_vOkHr9hY24SDMzkVM2iUOXfIhqzUiqUlvYrAtOFFk0w5uVVJbXYGfx7VBrBflBpn92jbUG7WOCJSMPV2leo-6k7u6JZ0omR8iphwnji-lXPZwAaFf8SAAS=s0-d)
Candido Dos Reis FJ, Clin Cancer Res. 2014 Nov 14
Candido Dos Reis FJ, Clin Cancer Res. 2014 Nov 14
Evidence for a time-dependent association between FOLR1 expression and survival from ovarian carcinoma: implications for clinical testing. An ovarian tumour tissue analysis consortium study.![External Web Site Icon External Web Site Icon](https://lh3.googleusercontent.com/blogger_img_proxy/AEn0k_vOkHr9hY24SDMzkVM2iUOXfIhqzUiqUlvYrAtOFFk0w5uVVJbXYGfx7VBrBflBpn92jbUG7WOCJSMPV2leo-6k7u6JZ0omR8iphwnji-lXPZwAaFf8SAAS=s0-d)
Köbel M, et al. Br J Cancer. 2014 Dec 9;111(12):2297-307
Köbel M, et al. Br J Cancer. 2014 Dec 9;111(12):2297-307
New strategies in ovarian cancer: translating the molecular complexity of ovarian cancer into treatment advances.![External Web Site Icon External Web Site Icon](https://lh3.googleusercontent.com/blogger_img_proxy/AEn0k_vOkHr9hY24SDMzkVM2iUOXfIhqzUiqUlvYrAtOFFk0w5uVVJbXYGfx7VBrBflBpn92jbUG7WOCJSMPV2leo-6k7u6JZ0omR8iphwnji-lXPZwAaFf8SAAS=s0-d)
Liu J, et al. Clin Cancer Res. 2014 Oct 15;20(20):5150-6
Liu J, et al. Clin Cancer Res. 2014 Oct 15;20(20):5150-6
Genomic classification of serous ovarian cancer with adjacent borderline differentiates RAS pathway and TP53-mutant tumors and identifies NRAS as an oncogenic driver.![External Web Site Icon External Web Site Icon](https://lh3.googleusercontent.com/blogger_img_proxy/AEn0k_vOkHr9hY24SDMzkVM2iUOXfIhqzUiqUlvYrAtOFFk0w5uVVJbXYGfx7VBrBflBpn92jbUG7WOCJSMPV2leo-6k7u6JZ0omR8iphwnji-lXPZwAaFf8SAAS=s0-d)
Emmanuel C, et al. Clin Cancer Res. 2014 Dec 15;20(24):6618-30.
Emmanuel C, et al. Clin Cancer Res. 2014 Dec 15;20(24):6618-30.
Knowledge-driven genomic interactions: an application in ovarian cancer.![External Web Site Icon External Web Site Icon](https://lh3.googleusercontent.com/blogger_img_proxy/AEn0k_vOkHr9hY24SDMzkVM2iUOXfIhqzUiqUlvYrAtOFFk0w5uVVJbXYGfx7VBrBflBpn92jbUG7WOCJSMPV2leo-6k7u6JZ0omR8iphwnji-lXPZwAaFf8SAAS=s0-d)
Kim D, Li R, et al. BioData Min. 2014 Sep 9;7:20
Kim D, Li R, et al. BioData Min. 2014 Sep 9;7:20
Ovarian cancer biomarkers: current state and future implications from high-throughput technologies.![External Web Site Icon External Web Site Icon](https://lh3.googleusercontent.com/blogger_img_proxy/AEn0k_vOkHr9hY24SDMzkVM2iUOXfIhqzUiqUlvYrAtOFFk0w5uVVJbXYGfx7VBrBflBpn92jbUG7WOCJSMPV2leo-6k7u6JZ0omR8iphwnji-lXPZwAaFf8SAAS=s0-d)
Leung F, et al. Adv Clin Chem. 2014;66:25-77.
Leung F, et al. Adv Clin Chem. 2014;66:25-77.
BRCA Testing in Action: Personal Stories - December 30, 2014
Feature: Peering into my genome,
by Jennifer Couzin-Frankel, Science Magazine, Dec 4
CDC blog post: Knowing BRCA changed my life, Debbie Wasserman Schultz (June, 2014)
The REAL story of Mary-Claire King,
by andrea, Brave Bosom Blog Post, Nov 20
Public Health Genomics in Action: Hereditary Breast and Ovarian Cancer - December 4, 2014
Hereditary breast and ovarian cancer in public health,
Genetic Alliance, webinar, Nov 21
Recent insights
Population testing for cancer predisposing BRCA1/BRCA2 mutations in the Ashkenazi-Jewish community: A randomized controlled trial.![External Web Site Icon External Web Site Icon](https://lh3.googleusercontent.com/blogger_img_proxy/AEn0k_vOkHr9hY24SDMzkVM2iUOXfIhqzUiqUlvYrAtOFFk0w5uVVJbXYGfx7VBrBflBpn92jbUG7WOCJSMPV2leo-6k7u6JZ0omR8iphwnji-lXPZwAaFf8SAAS=s0-d)
Ranjit Manchanda, et al. JNCI, January, 2015
Ranjit Manchanda, et al. JNCI, January, 2015
'Screen more' for cancer risk genes,
by James Gallagher, BBC, Nov 30
Breast and Ovarian Cancer Genetics: Clinical and Public Health Approaches - October 16, 2014
New CDC podcast: CDC Medscape Expert Commentary:Genetics and BRCA in Primary Care.
Katherine Kolor, October 13, 2014
CDC information: Does breast or ovarian cancer run in your family?
CDC BRCA assessment tool for women: The Know:BRCA Assessment can help you assess your risk of having a BRCA mutation. Learning your risk can help you and your doctor make important decisions for your health
CDC BRCA assessment tool for clinicians: Help women Know:BRCA
Assessing the genetic risk for BRCA-related breast or ovarian cancer in women: Recommendations from the U.S. Preventive Services Task Force![External Web Site Icon External Web Site Icon](https://lh3.googleusercontent.com/blogger_img_proxy/AEn0k_vOkHr9hY24SDMzkVM2iUOXfIhqzUiqUlvYrAtOFFk0w5uVVJbXYGfx7VBrBflBpn92jbUG7WOCJSMPV2leo-6k7u6JZ0omR8iphwnji-lXPZwAaFf8SAAS=s0-d)
Ann Intern Med. 2014;160(4):I-16. doi:10.7326/P14-9008
Ann Intern Med. 2014;160(4):I-16. doi:10.7326/P14-9008
CDC Public health genomics implementation tool kit for health departments- check out BRCA section
No hay comentarios:
Publicar un comentario